PUMA Welcomes Athletes to Budapest Ahead of World Athletics Championships
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes and media from around the world to the official opening of the PUMA House.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230819043891/en/
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes, and media from around the world to the official opening of the PUMA House. Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition. Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert. Watch the highlights video on PUMA YouTube. (Photo: Business Wire)
Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition.
Maria Valdes said: “2023 is a great year for us - it’s our 75th year anniversary – and we truly believe that track and field is the root of many sports. There are so many memorable moments we can look back on where track and field really represented our brand. From Tommie Smith back in 1968 to the numerous world records of Bolt just a couple of years ago. We hope to have more moments like this that can help shape us for years to come – starting here in Budapest.”
Karsten Warholm said: “Confidence is something you build. Obviously, it's not a given. If it is, it's not real. We prepare very well in training, and I think that is the secret to my confidence. My coach takes good care of me and the way we work, we always have control. And then of course when you go to a World Championship, you never know what you can pull out of the hat.”
Marcell Jacobs said: “Maybe I had too many injuries in the last two years… I really tried to overcome all of those problems. I'm the one who wants to be in a good shape, perfectly fit, and ready to face this very important challenge at the World Championships in Budapest.“
Julien Alfred said: “It's been fantastic to be part of the Puma family. Puma is a great brand who have paved the way for many of my idols and it feels great. And I really love the spikes as well!“
Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert.
Shericka Jackson said: “I've been working hard and there is no pressure for me. I'm in good shape and I'm going to show up, stay in my lane and focus on me.“
Rasheed Broadbell said: “It's really not a bad feeling [to not be the favourite], but a good thing, because the attention is not on me, so it's not really much pressure… But whoever the eyes is on, they have to ensure that they deliver. So for me, it's just keeping in my lane, stay focused and deliver.“
Hansle Parchment said: “Usually everybody is going to the US for college, but at the last minute we changed our minds to go to the University of the West Indies. I think that was a very good decision for me, otherwise I would have been running every weekend in the US. I'm very happy that I made that decision to stay in Jamaica.”
The World Athletics Championship Budapest 2023 will take place from 19-27 August.
Video:
To watch the full press conference – click here
To download the full press conference – click here
To watch the highlight video – click here
Images:
PUMA House imagery – click here
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230819043891/en/
Contact information
Media Contact: Stefan.Popovic@Puma.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 09:00:00 EET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.” Merz Therapeutics will share new findings reflecting its continued dedication to advancing neurotoxin science. These include: Lower Limb Spasticity Incobotulinumto
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 08:05:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additionally, Galderma and L’Oréal aim at exploring additional scientific research projects of mutual interest. This ongoing collaboration brings together Galderma’s scientific leadership i
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release
Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom